Induction of tumour cell shedding into effluent venous blood breast cancer surgery. by Choy, A. & McCulloch, P.
British Journal ofCancer(1996) 73, 79-82
© 1996 Stockton Press All rights reserved 0007-0920/96 $12.00 $
Induction of tumour cell shedding into effluent venous blood breast cancer
surgery
A Choy and P McCulloch
University Department ofSurgery, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK
Summary Surgeons have long been concerned that cancer may be disseminated by shedding of tumour cells
into the bloodstream during surgery. Early claims that cancer operations induced an increase in the number of
tumour cells shed into the circulation were subsequently discredited, and the issue has remained unresolved.
We used immunocytochemistry for cytokeratins to detect tumour cells in effluent blood from breast car-
cinomas in 18 patients undergoing surgery. Tumour cells were detectable in 6/18 patients during surgery, in
only one patient before operation and in none post-operatively (P = 0.025). Circulating cells were associated
with vascular invasion within the primary tumour (P = 0.032). No cytokeratin-positive cells were found in
blood from ten normal volunteers or four patients undergoing surgery for other breast conditions. These
results confirm that cancer surgery in humans results in an increase in the shedding of tumour cells into the
circulation. The implications for prognosis and practice should be determined by larger prospective studies.
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Blood-borne metastasis is the greatest obstacle to cure in
patients with cancer. Metastasis is a complex process by
which tumour cells enter blood vessels, circulate and exit the
system at distant sites (Hart and Saini, 1992). Trauma to
tumours increases both cell shedding and metastasis in
animal models (Tyzzer, 1913; Liotta et al., 1976), leading to
concern that cancer surgery might have similar effects in
humans. Early studies of cell shedding in humans were con-
founded by major sampling and cell identification errors, and
a general appreciation of the inadequacy of contemporary
techniques led to a decline in interest in the subject (Salsbury,
1975). In recent years emphasis in metastasis research has
shifted to the phenotype of the cancer cell, and a number of
enzymatic and adhesion molecules have been implicated in
the metastatic process (Fidler, 1991; Hart and Saini, 1992).
The importance of the extent of tumour cell shedding into
the bloodstream, and the effects of this on cancer surgery
have, by contrast, been neglected. The significance of these
factors in determining outcome therefore remains unknown.
Monoclonal antibodies against epithelial-restricted epitopes
now permit reliable identification of small numbers of car-
cinoma cells among large numbers of cells of haemopoetic
lineage in the bloodstream and bone marrow (Leather et al.,
1993; Pantel et al., 1993). Our ability to obtain samples of
effluent blood from tumour sites by selective venous cannula-
tion has also improved. Finally, new concerns over the
vulnerability of patients have arisen from studies demons-
trating the immunosuppressive effects of surgery. These have
shown that natural killer (NK) cell function and T cell
responses, believed to be central to the immune response to
cancer, are suppressed for 7-28 days after moderate to major
operations (Lennard et al., 1985; Sedman et al., 1988). The
potential induction of metastasis during cancer surgery
therefore needs to be reconsidered. An essential part of this
study must be to re-evaluate the effect of surgery on the
number of tumour cells shed into the bloodstream. We
therefore re-examined the phenomenon of intraoperative
tumour cell shedding in patients with breast cancer.
Materials and methods
Patients and sampling method
With the permission of the local Ethics Committee, 18
patients with operable (Union Internationale Contre le
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Cancer stages I and II) breast cancer were studied while
undergoing primary surgical treatment (simple mastectomy
or lumpectomy, together with level II axillary clearance). The
size, histological grade (Bloom and Richardson) and vascular
invasion of the primary tumour and the status of the axillary
lymph nodes were analysed by conventional histopatho-
logical methods. All cases were reviewed for this purpose by
a single pathologist (JN) unaware of the experimental results.
Four patients undergoing surgical excision of non-cancerous
breast lesions were also studied. Several hours before surgery,
a 'drum cartridge' central venous catheter (Abbot
Laboratories, UK) was inserted into the brachiocephalic vein
ipsilateral to the tumour at the antecubital fossa and the tip
manipulated under radiological guidance into the proximal
part of the ipsilateral subclavian vein. One 10 ml blood sample
was withdrawn immediately before operation, another three
during surgery and one 24 h later. The line was flushed with
heparinised saline solution between samples and this flush
discarded before each sample was taken. Samples were col-
lected into heparinised tubes and processed immediately.
Detection ofcirculating tumour cells
Blood samples (10 ml) were diluted with phosphate-buffered
saline (PBS) and subjected to differential density centrifuga-
tion over Ficoll-Hypaque medium (s.g. = 1.077; Pharmacia,
Sweden). Mononuclear cells from the interphase were washed
twice in PBS and resuspended in 5 ml of Dulbecco's modified
Eagle medium (Gibco, Paisley, UK). Ten cytospins per sam-
ple were prepared using a cytocentrifuge (Shandon, UK).
After 12-24 h air-drying, cytospin slides were fixed in dry
acetone for 10 min and incubated with monoclonal mouse
anti-human cytokeratin antibody MNF1 16 (Dako, High
Wycombe, UK) at a dilution of 1:100. This recognises a
common epitope on cytokeratins 10, 17 and 18 which are
expressed in cells of epithelial lineage but absent from
haemopoetic and lymphoid cells (Moll et al., 1982). The
antibody reaction was developed using the indirect
immunoenzyme APAAP (alkaline phosphatase-anti alkaline
phosphatase) technique, using levamisole to inhibit any
endogenous phosphatase activity. Red cytoplasmic staining
of positive cells was assessed by light microscopy.
Validation studies
The sensitivity and specificity of the antibody for breast
carcinoma cells in blood samples was evaluated by staining
cytospin preparations from human breast cancer cell lines
MCF7, ZR75 and MDA/MB231. These cells were uniformlySurgery induces tumour cell shedding in humans
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recognised when stained as pure culture preparations. Cells
from each of these cell lines were then mixed with 10 ml of
heparinised peripheral venous blood from healthy volunteers
in 10-fold dilutions from 103 to one cell ml-'. Cytospins were
prepared from the mononuclear cell layer of the entire 10 ml
sample, stained and counted as described. Ten cytospins were
prepared to ensure optimum examination of the entire sample.
The number of cytokeratin-stained cells in each cytospin was
recorded. The experiment was repeated ten times: thus a total
of 100 cytospins representing cells from 100 ml of blood were
counted at each cell dilution. Blind testing of normal blood
samples from ten healthy volunteers was carried out as a
negative control.
Statistics
Cell numbers detected were recorded, and cell numbers per
ml of blood calculated assuming a Poisson distribution. The
low yield and low total cell numbers per sample made exact
quantitative analysis inappropriate, so for statistical purposes
samples were scored as positive if any cytokeratin-positive
cells were observed on cytospin, and negative if none were
found. Proportions of positive and negative results were com-
pared for pre-, intra- and post-operative samples and the null
hypothesis (that operation makes no difference to proportion
of samples positive for cells) tested using McNemar's test.
For this purpose the intermediate of the three intraoperative
results was used. One-tailed P-values were used since the
hypothesis that operation reduced cell shedding was not con-
sidered. The relationship between individual prognostic
indicators and the presence of circulating cells during surgery
was analysed by Fisher's exact test.
Table I Mean cell recovery from in vitro seeding experiments
103 102 10 1
Cell dilution TCml-' TC ml-' TCml-' TCml-
Mean cell count 10 ml-' 532 46.2 3.1 0
Mean percentage cell 5.32 4.62 3.1 0
recovery
s.e.mean 47 5.7 0.55 1
s.d. 149 17.9 1.73 0.316
CI (95%)± 107 12.8 1.24 0.22
Each point is the mean of 100 counted cytospins. Error bars show
95% confidence limited (Poisson distribution assumed). TC, tumour
cells.
Results
Validation experiments
The mean numbers of cells detected per ml of blood is shown
in Table I. Cells could be consistently identified when mixed
with blood from normal volunteers at concentrations of ten
cells ml-' upwards. The yield of cells seeded into normal
samples ranged from 3.1% to 5.3%, showing a trend to
increase with increased initial cell concentration. The stan-
dard error varied from 0.47 to 0.55 at densities above one
cell ml-', at which level the method became too insensitive
for accurate evaluation. No false-positive results were found
in blood samples from normal volunteers.
Clinical study
Cells were detected in the blood of only one patient before
operation, in 6 of 18 during surgery, and in none 24 h after
operation (see Table II; Z = - 1.964, 1 d.f., P = 0.025, one-
tailed). In the one patient with detectable cells preoperatively,
the number of cells per ml of blood rose 8-fold during
surgery (from seven to a peak of 58 cells ml-1). Four of the
six patients with detectable cells during surgery had cells
present in all three intraoperative samples: the other two had
cells in two and one sample respectively (see Table IV). Of
eight patients with vascular/lymphatic invasion within the
primary tumour on histopathological examination, five were
positive for circulating cells during surgery, compared with
one of ten patients without invasion (P = 0.032, Fisher). No
relationship was apparent between detectability of circulating
cells and T stage, grade, or nodal status (Table III). No cells
were detected in the blood of three patients with benign
breast disease or one with intraduct carcinoma only.
Discussion
This study has demonstrated that breast cancer surgery
causes shedding of cancer cells into the effluent blood in
detectable numbers. The immunohistochemical techniques
used were shown to be highly specific and sensitive at cell
densities of ten tumour cells ml-' and above. Our observa-
tions are therefore not subject to the criticisms that dis-
credited previous studies of this phenomenon. Although the
yield of cells was small, the standard error obtained in vitro
confirmed the reliability of the sampling technique. The pro-
cess of tumour cell shedding is known to be intermittent, and
no accurate estimate of total tumour cell output over time
Table 1I Results of clinical studies
No of cells detected
Patient Operation Before During After T stage N stage Grade VI
I WLE and AD 7 58 0 1 - 2 +
2 WLE and AD 0 0 0 1 - I
3 WLE and AD 0 4 0 2 - 3
4 WLE 0 3 0 1 - 2 +
5 Mx and AD 0 0 0 2 - 2
6 WLE and AD 0 6 0 2 - 2 +
7 WLE and AD 0 0 0 2 - 2
8 Mx and AD 0 12 0 3 + 2 +
9 WLE and AD 0 0 0 1 + 3 +
10 WLE and AD 0 0 0 1 - 2 -
11 Mx and AD 0 0 0 2 + 2 -
12 Mx and AD 0 0 0 1 - 2 -
13 WLE and AD 0 0 0 2 - 2 +
14 Mx and AD 0 0 0 1 - 2
15 WLE and AD 0 8 0 2 + 3 +
16 WLE and AD 0 0 0 2 + 3 +
17 WLE and AD 0 0 0 2 - I
18 WLE and AD 0 0 0 1 - I
Numbers of tumour cells are the actual number recovered; approximate estimated number of
cells per ml = 20 x this, assuming a mean yield of 5%. The highest value of the three
intraoperative samples is recorded. Mx, mastectomy; AD, axillary dissection; WLE, wide local
excision; VI, vascular invasion.Surgery induces tumour cell shedding in humans
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Table III Results of clinical studies
Positive Negative
Vascular invasion*
+ 5 3
_ 1 9
T stage
1 2 5
2 4 7
Nodal status
+ 3 3
3 9
Grade (1/2/3)
1 0 3
2 4 7
3 2 2
Columns show patients either positive or negative for circulating
cells during the operation. *P<0.05 (Fisher). Numbers are numbers
of patients.
Table IV Number of tumour cells actually detected in the 18 cases of
breast cancer studied
Circulating cells found
Patient number Before surgery During surgery After surgery
Ist 2nd 3rd
1 7 8 58 5 0
2 0 0 0 0 0
3 0 2 4 1 0
4 0 3 1 1 0
5 0 0 0 0 0
6 0 0 0 6 0
7 0 0 0 0 0
8 0 8 0 12 0
9 0 0 0 0 0
10 0 0 0 0 0
11 0 0 0 0 0
12 0 0 0 0 0
13 0 0 0 0 0
14 0 0 0 0 0
15 0 3 1 8 0
16 0 0 0 0 0
17 0 0 0 0 0
18 0 0 0 0 0
The first intraoperative sample was taken within 5 min of the skin
incision, and the others at approximately Omin intervals thereafter.
can be made from these data. These are therefore essentially
qualitative results, but they clearly show a difference between
the prevalence of tumour cells in the effluent blood before
and during cancer surgery. More truly quantitative data may
be obtained if the yield of the method can be substantially
improved, for example by more extensive blood sampling
and semiautomated screening of cytospins. The use of
effluent blood samples is essential, since mixed venous blood
has already passed through a capillary bed since cell shed-
ding, and this leads to either entrapment or death of most
tumour cells (Fidler, 1991).
Two previous studies have reported on intraoperative
sampling of effluent venous blood from colon and renal
cancers, but neither determined whether surgery had any
effect on the rate of cell shedding (Glaves et al., 1988;
Leather et al., 1993). Preliminary results using a polymerase
chain reaction (PCR) technique to detect circulating tumour
cells were similar to our findings, although fewer patients
were studied (Brown et al., 1994). The association of cell
shedding with vascular invasion found in our patients is in
accordance with experimental findings in animal models, in
which metastatic potential is related both to tumour vas-
cularity and to the number of clumps of cells released (Liotta
et al., 1976). Current surgical opinion assigns little or no
importance to cell shedding induced by surgery, but there is
little scientific evidence to support this view. Tarin et al.
(1984) showed massive autotransfusion of tumour cells in
ascitic fluid does not necessarily induce metastasis in patients
whose cancers were already very advanced. The metabolic,
immunological and growth factor environment experienced
by cells shed during surgery from a primary tumour without
macroscopic metastases may be very different. Tarin's study
does not demonstrate that cell numbers are unimportant,
merely that other factors are also influential in determining
outcome. Studies of the 'no-touch' surgical technique failed
to show any survival benefit, but had ample scope for a type
II statistical error (failing to detect a real difference due to
lack of power). Surgery suppresses cellular immune function
and induces expression of growth factors that may stimulate
cell division in micrometastases (Lennard et al., 1985; Fisher
et al., 1989; Herlyn et al., 1990; McCarthy et al., 1991).
Surgery may indirectly induce the expression of integrin Ilb/
IIIAb on tumour cells by activating the coagulation system
and generating thrombin. This platelet-associated integrin
may enhance metastatic potential (Wojtukiewicz et al., 1992).
Our approach has proved sufficiently reliable to detect
tumour cells in blood samples above a threshold level of 10
cells per ml of blood. Other techniques, especially PCR have
been investigated for the same purpose, but none to date has
shown the specificity of immunohistochemistry in these
studies. Avoidance of false-positive findings is essential to the
validity of these experiments. It may be necessary to accept a
low sensitivity to ensure this, although refinement of the
method with semiautomated counting of larger numbers of
cytospins may improve this. Further developments in PCR
techniques may supplant or complement this approach in the
future.
This method, if validated in larger studies, may permit the
prognostic significance ofeffluent tumour cells during surgery
to be investigated in the clinical setting. If patients in whom
surgery causes increased tumour cell shedding prove to have
a poorer prognosis as a result of increased haematogenous
metastasis, discarded concepts of intraoperative vascular
isolation and 'no touch' techniques may need to be re-
evaluated. The significance of cell shedding rates in other
situations such as mammography and needle biopsy may also
require consideration. Larger studies to permit detailed subg-
roup analysis, follow-up and evaluation of prognostic
significance are now required to determine the clinical
significance of these observations.
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